The objective of the present study was to develop a heterogeneous catalyst for the hydrogenation of butanal that could function in the presence of CO and propene and, hence, could be used in a tandem reactor to enable the gas-phase conversion of propene and synthesis gas to butanol. To this end, we investigated the activity of silica-supported Shvo's catalyst (Shvo/SiO 2) for the gas-phase hydrogenation of butanal. Experiments were performed to determine the kinetics of n-and iso-butanal hydrogenation. The apparent activation energies and the apparent partial pressure dependencies of n-and iso-butanal, H 2 , and CO on the rates of n-and iso-butanol formation were determined. A mechanism for butanal hydrogenation was proposed to rationalize the observed kinetics and some of the reaction intermediates were observed by in situ infrared and 31 P MAS NMR spectroscopy. It was found that Shvo/SiO 2 was inhibited by SX (SX = sulfoxanthphos) and CO, and is inactive for alkene hydrogenation. The tandem catalytic conversion of propene and synthesis gas to butanol was then carried out using a SX-Rh supported ionic liquid phase (SILP) catalyst to promote the hydroformylation of propene to butanal and Shvo/SiO 2 to promote the hydrogenation of butanal to butanol. The rate expressions describing the kinetics of each of the catalysts were then used to predict operating conditions required to achieve high conversion of propene to butanol. Under the most favorable conditions examined (H 2 /CO = 10), an overall yield of 13% to butanol was achieved with 15% propene conversion and 90% aldehyde conversion at a temperature of 413 K.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.